Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pediatr Surg Int ; 16(4): 297-301, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10898233

RESUMO

Activities of hepatic xanthine oxidase (XO) and xanthine dehydrogenase (XD), serum liver enzymes, and reduced glutathione (GSH) were determined in livers of chronic cholestatic rats. The common bile duct was ligated (CBDL) and rats were randomized to either an untreated group or to treatment with allopurinol, a competitive XO inhibitor, or received a tungsten-supplemented diet to inactivate XO and XD, or received antioxidants vitamin C and vitamin E. One group underwent only sham laparotomy. After 4 weeks, in untreated CBDL animals serum aspartate aminotransferase and bilirubin concentrations were significantly elevated and hepatic GSH was significantly decreased when compared with the sham-operated group. Histochemical and enzymatic determinations of XD and XO showed a significant increase in hepatic XO activity after CBDL. Treatment with allopurinol and a tungsten-supplemented, molybdenum-free diet significantly attenuated serum liver enzymes, hepatic XO activity, and improved hepatic GSH levels, whereas vitamins C and E had a positive effect only on hepatic GSH levels. Our results support the hypothesis that cholestasis-induced hepatocellular injury is partially triggered by oxidative processes derived from increased hepatic XO activity. Inhibition and inactivation of XO exerts a hepatocellular protective effect in chronic cholestasis.


Assuntos
Colestase/enzimologia , Fígado/enzimologia , Xantina Desidrogenase/metabolismo , Xantina Oxidase/metabolismo , Alopurinol/farmacologia , Animais , Doença Crônica , Inibidores Enzimáticos/farmacologia , Glutationa/metabolismo , Masculino , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Tungstênio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...